Diagnosis and Treatment of Genitourinary Syndrome of Menopause

Ashley L. Hodges, Aimee C. Holland, Barbara Dehn, Diane Pace

Research output: Contribution to journalArticle

Abstract

Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life. Many women are not aware that symptoms can be controlled with treatment. Current treatment options approved for GSM include vaginal moisturizers, lubricants, and hormones. For women with GSM symptoms that are unresponsive to nonhormonal therapy, low-dose vaginal estrogen therapy is the preferred pharmacologic treatment. Clinicians should be trained to routinely ask appropriate questions during the history to elicit sufficient information to assess for GSM. Physical examination findings may further confirm suspicion of GSM.

Original languageEnglish (US)
Pages (from-to)423-430
Number of pages8
JournalNursing for Women's Health
Volume22
Issue number5
DOIs
StatePublished - Oct 1 2018

Fingerprint

Menopause
Atrophic Vaginitis
Therapeutics
Lubricants
Health Personnel
Physical Examination
Atrophy
Estrogens
History
Quality of Life
Hormones

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Cite this

Diagnosis and Treatment of Genitourinary Syndrome of Menopause. / Hodges, Ashley L.; Holland, Aimee C.; Dehn, Barbara; Pace, Diane.

In: Nursing for Women's Health, Vol. 22, No. 5, 01.10.2018, p. 423-430.

Research output: Contribution to journalArticle

Hodges, Ashley L. ; Holland, Aimee C. ; Dehn, Barbara ; Pace, Diane. / Diagnosis and Treatment of Genitourinary Syndrome of Menopause. In: Nursing for Women's Health. 2018 ; Vol. 22, No. 5. pp. 423-430.
@article{6ca9e67b40554733974e95e0e6e7977d,
title = "Diagnosis and Treatment of Genitourinary Syndrome of Menopause",
abstract = "Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life. Many women are not aware that symptoms can be controlled with treatment. Current treatment options approved for GSM include vaginal moisturizers, lubricants, and hormones. For women with GSM symptoms that are unresponsive to nonhormonal therapy, low-dose vaginal estrogen therapy is the preferred pharmacologic treatment. Clinicians should be trained to routinely ask appropriate questions during the history to elicit sufficient information to assess for GSM. Physical examination findings may further confirm suspicion of GSM.",
author = "Hodges, {Ashley L.} and Holland, {Aimee C.} and Barbara Dehn and Diane Pace",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.nwh.2018.07.005",
language = "English (US)",
volume = "22",
pages = "423--430",
journal = "Nursing for Women's Health",
issn = "1751-4851",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Diagnosis and Treatment of Genitourinary Syndrome of Menopause

AU - Hodges, Ashley L.

AU - Holland, Aimee C.

AU - Dehn, Barbara

AU - Pace, Diane

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life. Many women are not aware that symptoms can be controlled with treatment. Current treatment options approved for GSM include vaginal moisturizers, lubricants, and hormones. For women with GSM symptoms that are unresponsive to nonhormonal therapy, low-dose vaginal estrogen therapy is the preferred pharmacologic treatment. Clinicians should be trained to routinely ask appropriate questions during the history to elicit sufficient information to assess for GSM. Physical examination findings may further confirm suspicion of GSM.

AB - Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life. Many women are not aware that symptoms can be controlled with treatment. Current treatment options approved for GSM include vaginal moisturizers, lubricants, and hormones. For women with GSM symptoms that are unresponsive to nonhormonal therapy, low-dose vaginal estrogen therapy is the preferred pharmacologic treatment. Clinicians should be trained to routinely ask appropriate questions during the history to elicit sufficient information to assess for GSM. Physical examination findings may further confirm suspicion of GSM.

UR - http://www.scopus.com/inward/record.url?scp=85054058988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054058988&partnerID=8YFLogxK

U2 - 10.1016/j.nwh.2018.07.005

DO - 10.1016/j.nwh.2018.07.005

M3 - Article

C2 - 30170002

AN - SCOPUS:85054058988

VL - 22

SP - 423

EP - 430

JO - Nursing for Women's Health

JF - Nursing for Women's Health

SN - 1751-4851

IS - 5

ER -